A-share listed Chinese medical equipment manufacturer, MINDRAY BIO-MEDICAL(300760.SZ) -3.970 (-1.717%) , is considering a secondary IPO in Hong Kong, potentially raising at least US$1 billion (equivalent to about $7.8 billion), Bloomberg quoted insiders as saying. The company has also engaged in discussions with potential advisors regarding the possible share offering. MINDRAY BIO-MEDICAL responded to Jiemian.com saying that the matter is subject to official information.(A Shares quote is delayed for at least 15 mins.)Related NewsG Sachs Raises HKEX TP to HKD500, Lifts EPS Forecasts